Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: A systematic review and meta-analysis

Liver Transplantation

Volumn 19, Issue 12, 2013, Pages 1361-1369

  Singh, Siddharth ^a   Varayil, Jithinraj Edakkanambeth ^a   Loftus, Edward V ^a   Talwalkar, Jayant A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; COLON; COLONOSCOPY; COLORECTAL CANCER; FOLLOW UP; GEOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; META ANALYSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION;

CHOLANGITIS, SCLEROSING; COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; LIVER TRANSPLANTATION; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84889088336     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23741     Document Type: Review

References (41)

1. Singh S, Talwalkar JA,. Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol 2013; 11: 898-907.
2. Kashyap R, Safadjou S, Chen R, Mantry P, Sharma R, Patil V, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases-an analysis of the UNOS database. J Gastrointest Surg 2010; 14: 1362-1369.
3. Boonstra K, Beuers U, Ponsioen CY,. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012; 56: 1181-1188.
4. Loftus EV Jr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-96.
5. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO,. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002; 56: 48-54.
6. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR,. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427.
7. Sint Nicolaas J, de Jonge V, Steyerberg EW, Kuipers EJ, van Leerdam ME, Veldhuyzen-van Zanten SJ,. Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant 2010; 10: 868-876.
8. Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, et al. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Scand J Gastroenterol 2012; 47: 1021-1029.
9. Loftus EV Jr, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27: 685-690.
10. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003; 75: 1983-1988.
11. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. http://handbook.cochrane.org/whnjs.htm. Revised March 2011. Accessed August 2013.
12. Moher D, Liberati A, Tetzlaff J, Altman DG,; for PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
13. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F,. Methods for Meta-Analysis in Medical Research. Chichester, United Kingdom: Wiley; 2000.
14. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
16. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al.; for GRADE Working Group. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 2011; 64: 1294-1302.
17. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
18. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR,. Publication bias in clinical research. Lancet 1991; 337: 867-872.
19. Albright JB, Bonatti H, Stauffer J, Dickson RC, Nguyen J, Harnois D, et al. Colorectal and anal neoplasms following liver transplantation. Colorectal Dis 2010; 12: 657-666.
20. Bleday R, Lee E, Jessurun J, Heine J, Wong WD,. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36: 908-912.
21. Dvorchik I, Subotin M, Demetris AJ, Fung JJ, Starzl TE, Wieand S, Abu-Elmagd KM,. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002; 35: 380-384.
22. Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS, et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998; 176: 265-269.
23. Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997; 225: 472-481.
24. Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA,. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis. Inflamm Bowel Dis 2012; 18: 269-274.
25. Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141-1150.
26. Joshi D, Bjarnason I, Belgaumkar A, O'Grady J, Suddle A, Heneghan MA, et al. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int 2013; 33: 53-61.
27. Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M,. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995; 118: 615-619.
28. Koornstra JJ, Wesseling J, de Jong AE, Vasen HF, Kleibeuker JH, Haagsma EB,. Increased risk of colorectal neoplasia in asymptomatic liver-transplant recipients. Gut 2007; 56: 892-893.
29. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA,. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83: 1237-1243.
30. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL,. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22: 451-457.
31. Sint Nicolaas J, Tjon AS, Metselaar HJ, Kuipers EJ, de Man RA, van Leerdam ME,. Colorectal cancer in post-liver transplant recipients. Dis Colon Rectum 2010; 53: 817-821.
32. Moncrief KJ, Savu A, Ma MM, Bain VG, Wong WW, Tandon P,. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation-a single-centre experience. Can J Gastroenterol 2010; 24: 40-46.
33. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM,. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005; 80: 759-764.
34. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ,. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009; 137: 2010-2017.
35. Ho GT, Seddon AJ, Therapondos G, Satsangi J, Hayes PC,. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation. Eur J Gastroenterol Hepatol 2005; 17: 1379-1385.
36. Van de Vrie W, de Man RA, van Buuren HR, Schouten WR, Tilanus HW, Metselaar HJ,. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2003; 15: 657-663.
37. Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakizoe S, Starzl TE,. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11: 477-480.
38. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193-1200.
39. Johnson EE, Leverson GE, Pirsch JD, Heise CP,. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007; 11: 272-279.
40. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I,. The case of the misleading funnel plot. BMJ 2006; 333: 597-600.
41. Selgrad M, Koornstra JJ, Fini L, Blom M, Huang R, Devol EB, et al. JC virus infection in colorectal neoplasia that develops after liver transplantation. Clin Cancer Res 2008; 14: 6717-6721.